Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Agnosia × Sodium Chloride × Clear all

Phase

Status

Completed 3 Withdrawn 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 2 Leukemia, Myeloid, Acute 2 Waldenstrom Macroglobulinemia 1 Thrombocythemia, Essential 1 Sezary Syndrome 1 Rectal Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Pain, Intractable 1 Neoplasms, Plasma Cell 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Multiple Myeloma 1 Lymphoproliferative Disorders 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Lower Urinary Tract Symptoms 1

Interventions

Sodium Chloride 1 Sevoflurane 1 Propofol 1 Pregabalin 1 Ketamine 1 Anesthesia, Conduction 1 Analgesia 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01951911 2017-07-11

KETA-1

Haukeland University Hospital

Phase 3 Withdrawn

Agnosia, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡